Dr. Leena Gandhi most recently served as Director of Thoracic Medical Oncology at NYU Perlmutter Cancer Center. She has spent her career taking care of lung cancer patients and running clinical trials. Her research is focused on understanding how and why patients respond to therapy by evaluating certain markers–genetic changes, proteins, and other features–in blood or tumor tissue.
Dr. Gandhi’s is currently the lead of immuno-oncology medical development at Eli Lilly. She’s heading up a team tasked with overseeing the advancement of Lilly’s portfolio of immuno-oncology prospects.
